SUMMARY Forty nine infants of HIV seropositive women were followed up for a median of 24 months, together with 24 controls. The infection status of 11 index children under 18 months of age was indeterminate; 34 were presumed uninfected while four showed clinical and laboratory evidence of HIV disease. Based on current definitions of HIV infection and excluding children under 18 months old as well as those who had not been studied from birth, two out of 28 children were infected. The estimated rate of maternofetal transmission was therefore 7-1%. In children with proved infection, sequential laboratory data showed that hypergammaglobulinaemia was noted as early as 6 months and often predated clinical signs. This observation, in the presence of non-specific clinical findings, was helpful in alerting the paediatrician to a diagnosis of HIV infection.
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Vertical transmission of the human immunodeficiency virus (HIV) is now well documented, -3 although the exact risk has not yet been quantified. Rates of transmission appear to vary from 22-65%, depending on inclusion criteria and duration of the study as well as methods used to define paediatric HIV infection." The diagnostic value of an HIV antibody test is limited by the presence of passively acquired maternal antibody in infants. Clinical evidence of infection is also unreliable, especially in the early stages when signs and symptoms are nonspecific. 7 The inclusion of control children is therefore essential, in order that clinical and laboratory parameters can be evaluated. So far, no study of mother to child transmission of HIV has included a control group.
In the United Kingdom, Edinburgh has been reported to have the largest population of intravenous drug users infected with HIV, one third of whom are young women. Table 3 summarises perinatal data of index and control children, with the index cohort separated into children who were infected and those presumed uninfected. The mean birth weight was significantly lower in index children presumed uninfected (95% confidence interval (CI) 2714 to 3078 g) when compared with controls, (95% CI 3069 to 3527 g) and the difference remained when all children whose mothers used drugs during pregnancy were excluded from analysis. The effect of preterm delivery was allowed for by extrapolating preterm birth weight to term, along the same centile, and index children presumed uninfected were significantly lighter than controls.
All but one index infant were delivered by spontaneous vaginal delivery. Neonatal special care was required mainly for drug withdrawal symptoms and intrauterine growth retardation. Intensive care was only necessary for two index infants because of problems arising from preterm delivery. These consisted of meningitis with septicaemia resulting in ventriculoperitoneal shunts for hydrocephalus Most index mothers were infected through needle sharing during intravenous drug use. As most of these women come from areas of multiple deprivation, this is likely to adversely affect their infant's health and development. A previous study from Edinburgh of women who identified themselves as being at risk of HIV infection showed no significant differences in social characteristics of those who subsequently tested HIV positive, compared with HIV negative women.'3 Rather, similarities were seen in infant morbidity (low birth weight, intrauterine growth retardation, preterm delivery) in both groups of women, which were increased three fold when compared with the general population. Our choice of control infants was such that both groups were comparable in social and epidemiological factors, as well as maternal intravenous drug use during pregnancy. Despite that, the mean birth weight of the index infants presumed uninfected was significantly lower than that of controls, allowing for maternal drug use and prematurity. This could be a direct effect of HIV during pregnancy.
In estimating the vertical transmission rate, we had excluded children under 18 Recent developments in diagnostic techniques, such as in vitro production of HIV specific antibody,'6 or polymerase chain reactions for amplification of viral DNA,'7 are still under evaluation and not routinely available. A recent study found that six of 14 asymptomatic newborns, and five of 10 seronegative children of infected mothers were positive for HIV-DNA, using the polymerase chain reaction technique.'8 Using more sophisticated tests, the numbers of infected children in our cohort could be higher. There is, however, an urgent need for improved methods to evaluate the seronegative index children who remain clinically well with normal immune function, as four mothers have embarked on subsequent pregnancies based purely on the observation that the index child was symptom free and antibody negative (presumed uninfected).
We were unable to detect any laboratory predictor of HIV disease when sequential index and control data were compared. In the children with proved infection, immunoglobulin concentrations (especially IgG) did, however, start to rise before clinical signs were obvious. Clinical manifestations are non-specific, but when seen in conjunction with laboratory abnormalities (hypergammaglobulinaemia, T4 lymphopenia, thrombocytopenia), a diagnosis of HIV infection can be strongly suspected in a child especially when mother has engaged in high risk activities.
In future, we hope to use the polymerase chain reaction to detect HIV-DNA in the index children presumed uninfected. It must be stressed that the demonstration of viral DNA sequences does not imply overt infection, as little is known about the immune response to HIV in children infected antenatally. Our study stresses the importance of zontinued careful follow up of all children at risk of HIV infection, to detect early markers of infection is well as to determine the outcome of those who ippear symptom free.
